1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Urinary Tract Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Urothelial Carcinoma 1.2.3 Squamous Cell Carcinoma 1.2.4 Adenocarcinoma 1.2.5 Others 1.3 Market by Application 1.3.1 Global Urinary Tract Cancer Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Research Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Urinary Tract Cancer Market Perspective (2018-2029) 2.2 Urinary Tract Cancer Growth Trends by Region 2.2.1 Global Urinary Tract Cancer Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Urinary Tract Cancer Historic Market Size by Region (2018-2023) 2.2.3 Urinary Tract Cancer Forecasted Market Size by Region (2024-2029) 2.3 Urinary Tract Cancer Market Dynamics 2.3.1 Urinary Tract Cancer Industry Trends 2.3.2 Urinary Tract Cancer Market Drivers 2.3.3 Urinary Tract Cancer Market Challenges 2.3.4 Urinary Tract Cancer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Urinary Tract Cancer Players by Revenue 3.1.1 Global Top Urinary Tract Cancer Players by Revenue (2018-2023) 3.1.2 Global Urinary Tract Cancer Revenue Market Share by Players (2018-2023) 3.2 Global Urinary Tract Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Urinary Tract Cancer Revenue 3.4 Global Urinary Tract Cancer Market Concentration Ratio 3.4.1 Global Urinary Tract Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Cancer Revenue in 2022 3.5 Urinary Tract Cancer Key Players Head office and Area Served 3.6 Key Players Urinary Tract Cancer Product Solution and Service 3.7 Date of Enter into Urinary Tract Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Urinary Tract Cancer Breakdown Data by Type 4.1 Global Urinary Tract Cancer Historic Market Size by Type (2018-2023) 4.2 Global Urinary Tract Cancer Forecasted Market Size by Type (2024-2029) 5 Urinary Tract Cancer Breakdown Data by Application 5.1 Global Urinary Tract Cancer Historic Market Size by Application (2018-2023) 5.2 Global Urinary Tract Cancer Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Urinary Tract Cancer Market Size (2018-2029) 6.2 North America Urinary Tract Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Urinary Tract Cancer Market Size by Country (2018-2023) 6.4 North America Urinary Tract Cancer Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Urinary Tract Cancer Market Size (2018-2029) 7.2 Europe Urinary Tract Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Urinary Tract Cancer Market Size by Country (2018-2023) 7.4 Europe Urinary Tract Cancer Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Urinary Tract Cancer Market Size (2018-2029) 8.2 Asia-Pacific Urinary Tract Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Urinary Tract Cancer Market Size by Region (2018-2023) 8.4 Asia-Pacific Urinary Tract Cancer Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Urinary Tract Cancer Market Size (2018-2029) 9.2 Latin America Urinary Tract Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Urinary Tract Cancer Market Size by Country (2018-2023) 9.4 Latin America Urinary Tract Cancer Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Urinary Tract Cancer Market Size (2018-2029) 10.2 Middle East & Africa Urinary Tract Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Urinary Tract Cancer Market Size by Country (2018-2023) 10.4 Middle East & Africa Urinary Tract Cancer Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Spectrum Pharmaceuticals Boehringer Ingelheim 11.1.1 Spectrum Pharmaceuticals Boehringer Ingelheim Company Detail 11.1.2 Spectrum Pharmaceuticals Boehringer Ingelheim Business Overview 11.1.3 Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Introduction 11.1.4 Spectrum Pharmaceuticals Boehringer Ingelheim Revenue in Urinary Tract Cancer Business (2018-2023) 11.1.5 Spectrum Pharmaceuticals Boehringer Ingelheim Recent Development 11.2 Bristol-Myers Squibb Company 11.2.1 Bristol-Myers Squibb Company Company Detail 11.2.2 Bristol-Myers Squibb Company Business Overview 11.2.3 Bristol-Myers Squibb Company Urinary Tract Cancer Introduction 11.2.4 Bristol-Myers Squibb Company Revenue in Urinary Tract Cancer Business (2018-2023) 11.2.5 Bristol-Myers Squibb Company Recent Development 11.3 Genzyme Corporation 11.3.1 Genzyme Corporation Company Detail 11.3.2 Genzyme Corporation Business Overview 11.3.3 Genzyme Corporation Urinary Tract Cancer Introduction 11.3.4 Genzyme Corporation Revenue in Urinary Tract Cancer Business (2018-2023) 11.3.5 Genzyme Corporation Recent Development 11.4 F. Hoffmann-La Roche 11.4.1 F. Hoffmann-La Roche Company Detail 11.4.2 F. Hoffmann-La Roche Business Overview 11.4.3 F. Hoffmann-La Roche Urinary Tract Cancer Introduction 11.4.4 F. Hoffmann-La Roche Revenue in Urinary Tract Cancer Business (2018-2023) 11.4.5 F. Hoffmann-La Roche Recent Development 11.5 Shionogi 11.5.1 Shionogi Company Detail 11.5.2 Shionogi Business Overview 11.5.3 Shionogi Urinary Tract Cancer Introduction 11.5.4 Shionogi Revenue in Urinary Tract Cancer Business (2018-2023) 11.5.5 Shionogi Recent Development 11.6 Kyowa Hakko Kirin 11.6.1 Kyowa Hakko Kirin Company Detail 11.6.2 Kyowa Hakko Kirin Business Overview 11.6.3 Kyowa Hakko Kirin Urinary Tract Cancer Introduction 11.6.4 Kyowa Hakko Kirin Revenue in Urinary Tract Cancer Business (2018-2023) 11.6.5 Kyowa Hakko Kirin Recent Development 11.7 Medical Enzymes 11.7.1 Medical Enzymes Company Detail 11.7.2 Medical Enzymes Business Overview 11.7.3 Medical Enzymes Urinary Tract Cancer Introduction 11.7.4 Medical Enzymes Revenue in Urinary Tract Cancer Business (2018-2023) 11.7.5 Medical Enzymes Recent Development 11.8 IkerChem 11.8.1 IkerChem Company Detail 11.8.2 IkerChem Business Overview 11.8.3 IkerChem Urinary Tract Cancer Introduction 11.8.4 IkerChem Revenue in Urinary Tract Cancer Business (2018-2023) 11.8.5 IkerChem Recent Development 11.9 Amgen 11.9.1 Amgen Company Detail 11.9.2 Amgen Business Overview 11.9.3 Amgen Urinary Tract Cancer Introduction 11.9.4 Amgen Revenue in Urinary Tract Cancer Business (2018-2023) 11.9.5 Amgen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Urinary Tract Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Urothelial Carcinoma Table 3. Key Players of Squamous Cell Carcinoma Table 4. Key Players of Adenocarcinoma Table 5. Key Players of Others Table 6. Global Urinary Tract Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Urinary Tract Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Urinary Tract Cancer Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Urinary Tract Cancer Market Share by Region (2018-2023) Table 10. Global Urinary Tract Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Urinary Tract Cancer Market Share by Region (2024-2029) Table 12. Urinary Tract Cancer Market Trends Table 13. Urinary Tract Cancer Market Drivers Table 14. Urinary Tract Cancer Market Challenges Table 15. Urinary Tract Cancer Market Restraints Table 16. Global Urinary Tract Cancer Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Urinary Tract Cancer Market Share by Players (2018-2023) Table 18. Global Top Urinary Tract Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Cancer as of 2022) Table 19. Ranking of Global Top Urinary Tract Cancer Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Urinary Tract Cancer Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Urinary Tract Cancer Product Solution and Service Table 23. Date of Enter into Urinary Tract Cancer Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Urinary Tract Cancer Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Urinary Tract Cancer Revenue Market Share by Type (2018-2023) Table 27. Global Urinary Tract Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Urinary Tract Cancer Revenue Market Share by Type (2024-2029) Table 29. Global Urinary Tract Cancer Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Urinary Tract Cancer Revenue Market Share by Application (2018-2023) Table 31. Global Urinary Tract Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Urinary Tract Cancer Revenue Market Share by Application (2024-2029) Table 33. North America Urinary Tract Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Urinary Tract Cancer Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Urinary Tract Cancer Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Urinary Tract Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Urinary Tract Cancer Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Urinary Tract Cancer Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Urinary Tract Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Urinary Tract Cancer Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Urinary Tract Cancer Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Urinary Tract Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Urinary Tract Cancer Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Urinary Tract Cancer Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Urinary Tract Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Urinary Tract Cancer Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Urinary Tract Cancer Market Size by Country (2024-2029) & (US$ Million) Table 48. Spectrum Pharmaceuticals Boehringer Ingelheim Company Detail Table 49. Spectrum Pharmaceuticals Boehringer Ingelheim Business Overview Table 50. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Product Table 51. Spectrum Pharmaceuticals Boehringer Ingelheim Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 52. Spectrum Pharmaceuticals Boehringer Ingelheim Recent Development Table 53. Bristol-Myers Squibb Company Company Detail Table 54. Bristol-Myers Squibb Company Business Overview Table 55. Bristol-Myers Squibb Company Urinary Tract Cancer Product Table 56. Bristol-Myers Squibb Company Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 57. Bristol-Myers Squibb Company Recent Development Table 58. Genzyme Corporation Company Detail Table 59. Genzyme Corporation Business Overview Table 60. Genzyme Corporation Urinary Tract Cancer Product Table 61. Genzyme Corporation Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 62. Genzyme Corporation Recent Development Table 63. F. Hoffmann-La Roche Company Detail Table 64. F. Hoffmann-La Roche Business Overview Table 65. F. Hoffmann-La Roche Urinary Tract Cancer Product Table 66. F. Hoffmann-La Roche Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 67. F. Hoffmann-La Roche Recent Development Table 68. Shionogi Company Detail Table 69. Shionogi Business Overview Table 70. Shionogi Urinary Tract Cancer Product Table 71. Shionogi Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 72. Shionogi Recent Development Table 73. Kyowa Hakko Kirin Company Detail Table 74. Kyowa Hakko Kirin Business Overview Table 75. Kyowa Hakko Kirin Urinary Tract Cancer Product Table 76. Kyowa Hakko Kirin Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 77. Kyowa Hakko Kirin Recent Development Table 78. Medical Enzymes Company Detail Table 79. Medical Enzymes Business Overview Table 80. Medical Enzymes Urinary Tract Cancer Product Table 81. Medical Enzymes Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 82. Medical Enzymes Recent Development Table 83. IkerChem Company Detail Table 84. IkerChem Business Overview Table 85. IkerChem Urinary Tract Cancer Product Table 86. IkerChem Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 87. IkerChem Recent Development Table 88. Amgen Company Detail Table 89. Amgen Business Overview Table 90. Amgen Urinary Tract Cancer Product Table 91. Amgen Revenue in Urinary Tract Cancer Business (2018-2023) & (US$ Million) Table 92. Amgen Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Urinary Tract Cancer Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Urinary Tract Cancer Market Share by Type: 2022 VS 2029 Figure 3. Urothelial Carcinoma Features Figure 4. Squamous Cell Carcinoma Features Figure 5. Adenocarcinoma Features Figure 6. Others Features Figure 7. Global Urinary Tract Cancer Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Urinary Tract Cancer Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Research Centers Case Studies Figure 12. Others Case Studies Figure 13. Urinary Tract Cancer Report Years Considered Figure 14. Global Urinary Tract Cancer Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Urinary Tract Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Urinary Tract Cancer Market Share by Region: 2022 VS 2029 Figure 17. Global Urinary Tract Cancer Market Share by Players in 2022 Figure 18. Global Top Urinary Tract Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Cancer as of 2022) Figure 19. The Top 10 and 5 Players Market Share by Urinary Tract Cancer Revenue in 2022 Figure 20. North America Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. North America Urinary Tract Cancer Market Share by Country (2018-2029) Figure 22. United States Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Canada Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Urinary Tract Cancer Market Share by Country (2018-2029) Figure 26. Germany Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Urinary Tract Cancer Market Share by Region (2018-2029) Figure 34. China Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Japan Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. South Korea Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Southeast Asia Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. India Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Australia Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Urinary Tract Cancer Market Share by Country (2018-2029) Figure 42. Mexico Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Brazil Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Urinary Tract Cancer Market Share by Country (2018-2029) Figure 46. Turkey Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Saudi Arabia Urinary Tract Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Spectrum Pharmaceuticals Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 49. Bristol-Myers Squibb Company Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 50. Genzyme Corporation Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 52. Shionogi Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 53. Kyowa Hakko Kirin Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 54. Medical Enzymes Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 55. IkerChem Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 56. Amgen Revenue Growth Rate in Urinary Tract Cancer Business (2018-2023) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Spectrum Pharmaceuticals Boehringer Ingelheim Bristol-Myers Squibb Company Genzyme Corporation F. Hoffmann-La Roche Shionogi Kyowa Hakko Kirin Medical Enzymes IkerChem Amgen